TY  - GEN
AU  - Harigai,Masayoshi
AU  - Winthrop,Kevin
AU  - Takeuchi,Tsutomu
AU  - Hsieh,Tsu-Yi
AU  - Chen,Yi-Ming
AU  - Smolen,Josef S
AU  - Burmester,Gerd
AU  - Walls,Chad
AU  - Wu,Wen-Shuo
AU  - Dickson,Christina
AU  - Liao,Ran
AU  - Genovese,Mark C
TI  - Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
SN  - 2056-5933
PY  - 2021///0419
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antirheumatic Agents
KW  - adverse effects
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Arthritis, Rheumatoid
KW  - complications
KW  - Azetidines
KW  - administration & dosage
KW  - Female
KW  - Hepatitis B
KW  - chemically induced
KW  - Hepatitis B Antibodies
KW  - blood
KW  - Hepatitis B Surface Antigens
KW  - Hepatitis B virus
KW  - drug effects
KW  - Humans
KW  - Immunomodulation
KW  - Janus Kinase Inhibitors
KW  - Japan
KW  - epidemiology
KW  - Latent Infection
KW  - Male
KW  - Middle Aged
KW  - Purines
KW  - Pyrazoles
KW  - Retrospective Studies
KW  - Sulfonamides
KW  - Tumor Necrosis Factor Inhibitors
KW  - Virus Activation
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/rmdopen-2019-001095
ER  -